Keyphrases
Microparticles
100%
VEGF165
100%
Endothelial Progenitor Cells
100%
MicroRNA-17
100%
Vascular Endothelial Growth Factor
83%
Ischemic Disease
33%
CDKN1A
33%
MiR-17
33%
CircZNF652
33%
Clinical Evaluation
16%
Cell-based
16%
Poor Survival
16%
Cell Survival
16%
Akt Phosphorylation
16%
Proangiogenic Cells
16%
Therapeutic Effect
16%
Pro-survival
16%
Vascular Endothelial Growth Factor Receptor 2 (VEGFR2)
16%
Cord Blood
16%
Cell Aggregates
16%
Endothelial Progenitors
16%
Therapeutic Efficacy
16%
High Survival
16%
Paracrine Action
16%
Engraftment
16%
Engraftment Rate
16%
Cell Forces
16%
Blood Outgrowth Endothelial Cells
16%
Neuroscience
Vascular Endothelial Growth Factor
100%
Progenitor Cell
100%
MicroRNA
100%
In Vivo
37%
Ischemia
25%
In Vitro
12%
Cell Survival
12%
Cell Therapy
12%
Kinase Insert Domain Receptor
12%
Cell Aggregation
12%
Pharmacology, Toxicology and Pharmaceutical Science
Microparticle
100%
Vasculotropin
100%
microRNA
100%
Ischemia
25%
Combination Therapy
12%
Clinical Trial
12%
Therapeutic Effect
12%
Vasculotropin Receptor 2
12%
Biochemistry, Genetics and Molecular Biology
Vascular Endothelial Growth Factor
100%
MicroRNA
100%
Endothelial Progenitor Cell
100%
Cell Survival
12%
Clinical Trial
12%
Kinase Insert Domain Receptor
12%
Cell Aggregation
12%
Protein Kinase B
12%
Agricultural and Biological Sciences
Vascular Endothelial Growth Factor
100%
Endothelial Progenitor Cell
100%
MicroRNA
100%
Ischemia
25%
Kinase Insert Domain Receptor
12%
Cord Blood
12%
Immunology and Microbiology
Vasculotropin
100%
Endothelial Progenitor Cell
100%
Engraftment
25%
Cell Survival
12%
Kinase Insert Domain Receptor
12%
Cell Aggregation
12%